Trial Profile
Feasibility study of S-1 for adjuvant chemotherapy in Biliary-Pancreatic cancer
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 01 Feb 2021
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Biliary cancer; Pancreatic cancer
- Focus Adverse reactions
- 04 Mar 2013 New trial record